Publication | Closed Access

P84 High dose epirubicin and cyclophosphamide (EC) vs cyclophosphamide, methotrexate, fluorouracil (CMF) as adjuvant chemotherapy in high risk premenopausal breast cancer patients (PTS). A prospective randomized trial

Breast OncologyOncologyPharmacologyAdjuvant ChemotherapyBreast CancerPharmacotherapyCancer TreatmentVs CyclophosphamideMedicine